Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2018 2
2020 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Social, cultural and economic aspects of antimicrobial resistance.
Minssen T, Outterson K, Rogers Van Katwyk S, Batista PHD, Chandler CIR, Ciabuschi F, Harbarth S, Kesselheim AS, Laxminarayan R, Liddell K, Osterholm MT, Price L, Hoffman SJ. Minssen T, et al. Among authors: ciabuschi f. Bull World Health Organ. 2020 Dec 1;98(12):823-823A. doi: 10.2471/BLT.20.275875. Bull World Health Organ. 2020. PMID: 33293739 Free PMC article. No abstract available.
Challenges and shortcomings of antibacterial discovery projects.
Theuretzbacher U, Baraldi E, Ciabuschi F, Callegari S. Theuretzbacher U, et al. Among authors: ciabuschi f. Clin Microbiol Infect. 2023 May;29(5):610-615. doi: 10.1016/j.cmi.2022.11.027. Epub 2022 Dec 8. Clin Microbiol Infect. 2023. PMID: 36503116 Free PMC article.
To the G20: incentivising antibacterial research and development.
Årdal C, Baraldi E, Ciabuschi F, Outterson K, Rex JH, Piddock LJV, Findlay D; DRIVE-AB Steering Committee. Årdal C, et al. Among authors: ciabuschi f. Lancet Infect Dis. 2017 Aug;17(8):799-801. doi: 10.1016/S1473-3099(17)30404-8. Epub 2017 Jul 7. Lancet Infect Dis. 2017. PMID: 28689703 No abstract available.
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation.
Årdal C, Baraldi E, Busse R, Castro R, Ciabuschi F, Cisneros JM, Gyssens IC, Harbarth S, Kostyanev T, Lacotte Y, Magrini N, McDonnell A, Monnier AA, Moon S, Mossialos E, Peñalva G, Ploy MC, Radulović M, Ruiz AA, Røttingen JA, Sharland M, Tacconelli E, Theuretzbacher U, Vogler S, Sönksen UW, Åkerfeldt K, Cars O, O'Neill J. Årdal C, et al. Among authors: ciabuschi f. Lancet. 2024 Jan 13;403(10422):e2-e4. doi: 10.1016/S0140-6736(23)00282-9. Epub 2023 Feb 9. Lancet. 2024. PMID: 36774936 No abstract available.
Antibiotic research and development: business as usual?
Harbarth S, Theuretzbacher U, Hackett J; DRIVE-AB consortium. Harbarth S, et al. J Antimicrob Chemother. 2015;70(6):1604-7. doi: 10.1093/jac/dkv020. Epub 2015 Feb 10. J Antimicrob Chemother. 2015. PMID: 25673635
Simulating Market Entry Rewards for Antibiotics Development.
Okhravi C, Callegari S, McKeever S, Kronlid C, Baraldi E, Lindahl O, Ciabuschi F. Okhravi C, et al. Among authors: ciabuschi f. J Law Med Ethics. 2018 Jun;46(1_suppl):32-42. doi: 10.1177/1073110518782913. J Law Med Ethics. 2018. PMID: 30146961